Flora Peyvandi/X
Nov 17, 2025, 08:30
Emicizumab Shows Strong Safety and Effectiveness in Hemophilia A․New Findings From ATHN 7
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared an article on X:
” Safety and Effectiveness of Emicizumab in People With Haemophilia A in ATHN 7-no new safety signals were identified.
ABRs were similar for participants with or without FVIII inhibitors, across different severities of HA.”
Read full Abstract here.
Stay updated with Hemostasis Today.
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
-
May 26, 2026, 15:22Shazmah Shaikh: One Visual Guide to Understand All Major Anticoagulants
-
May 26, 2026, 14:39Chidinma Favour։ Welcome to Day 25 of My 31-Day Stroke Awareness Series
-
May 26, 2026, 14:35Novel Insights Into Congenital and Acquired Coagulopathies – ICHCC
-
May 26, 2026, 14:24Fernanda Orsi: The Growing Impact of Hematology Research in Latin America
-
May 26, 2026, 14:23Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?